Bank Of America Corp Tarsus Pharmaceuticals, Inc. Transaction History

Bank Of America Corp

$1.21 Trillion
Q1 2025

A detailed history of Bank Of America Corp transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 429,144 shares of TARS stock, worth $19.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

429,144

Previous 337,856 27.02%

Holding current value

$19.2 Million

Previous $18.7 Million 17.84%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$41.29 - $56.94 $3.77 Million - $5.2 Million	91,288 Added 27.02%	429,144 $22 Million
Q4 2024 Feb 14, 2025	BUY	$32.27 - $55.37 $3.37 Million - $5.78 Million	104,388 Added 44.71%	337,856 $18.7 Million
Q3 2024 Nov 14, 2024	SELL	$21.54 - $34.6 $207,731 - $333,682	-9,644 Reduced 3.97%	233,468 $7.68 Million
Q2 2024 Aug 14, 2024	BUY	$25.17 - $38.73 $342,815 - $527,502	13,620 Added 5.93%	243,112 $6.61 Million
Q1 2024 May 15, 2024	SELL	$19.61 - $39.22 $182,980 - $365,961	-9,331 Reduced 3.91%	229,492 $8.34 Million
Q4 2023 Feb 14, 2024	BUY	$12.98 - $20.73 $1.48 Million - $2.37 Million	114,317 Added 91.82%	238,823 $4.84 Million
Q2 2023 Aug 14, 2023	BUY	$11.57 - $19.63 $1.17 Million - $1.99 Million	101,547 Added 442.3%	124,506 $2.25 Million
Q1 2023 May 12, 2023	BUY	$11.92 - $16.27 $88,386 - $120,642	7,415 Added 47.7%	22,959 $288,000
Q4 2022 Feb 10, 2023	BUY	$14.12 - $18.72 $55,406 - $73,457	3,924 Added 33.77%	15,544 $227,000
Q3 2022 Nov 14, 2022	SELL	$14.08 - $18.5 $187,630 - $246,531	-13,326 Reduced 53.42%	11,620 $199,000
Q2 2022 Aug 12, 2022	BUY	$11.08 - $19.08 $204,392 - $351,968	18,447 Added 283.84%	24,946 $364,000
Q1 2022 May 16, 2022	SELL	$14.49 - $24.28 $60,321 - $101,077	-4,163 Reduced 39.05%	6,499 $109,000
Q4 2021 Feb 08, 2022	BUY	$21.21 - $29.68 $103,738 - $145,164	4,891 Added 84.75%	10,662 $240,000
Q3 2021 Nov 15, 2021	BUY	$21.45 - $29.22 $81,745 - $111,357	3,811 Added 194.44%	5,771 $125,000
Q2 2021 Sep 13, 2021	BUY	$27.16 - $38.59 $53,233 - $75,636	1,960 New	1,960 $57,000

Others Institutions Holding TARS

# of Institutions

200

Shares Held

44.5M

Call Options Held

19.9K

Put Options Held

7.6K

View Full List

About Tarsus Pharmaceuticals, Inc.

Ticker TARS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,658,500
Market Cap $1.2B
Description
Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...

More about TARS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Tarsus Pharmaceuticals, Inc. Transaction History